HighTower Advisors, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$14,000
-62.2%
21,588
-40.2%
0.00%
Q3 2022$37,000
+164.3%
36,074
+67.1%
0.00%
Q2 2022$14,000
-33.3%
21,585
-12.2%
0.00%
Q1 2022$21,000
-53.3%
24,585
-11.7%
0.00%
Q4 2021$45,000
-32.8%
27,8380.0%0.00%
Q3 2021$67,000
+3.1%
27,838
+13.2%
0.00%
Q2 2021$65,000
-47.2%
24,585
-0.3%
0.00%
Q1 2021$123,000
+241.7%
24,660
+9.2%
0.00%
Q4 2020$36,000
+100.0%
22,585
+15.3%
0.00%
Q3 2020$18,000
-10.0%
19,585
+0.0%
0.00%
Q2 2020$20,00019,5840.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders